Dialysis therapy is associated with peripheral marginal zone B-cell augmentation.
Adolescent
Adult
Aged
B-Lymphocytes
/ immunology
Dendritic Cells
/ immunology
Dialysis
Enzyme-Linked Immunospot Assay
Female
Humans
Immunologic Memory
Male
Middle Aged
Renal Insufficiency, Chronic
/ immunology
Spleen
/ pathology
T-Lymphocytes
/ immunology
Tumor Necrosis Factor Receptor Superfamily, Member 7
/ metabolism
Young Adult
Chronic kidney disease stage 5 (CKD5)
Dialysis
Marginal zone B cells
Journal
Transplant immunology
ISSN: 1878-5492
Titre abrégé: Transpl Immunol
Pays: Netherlands
ID NLM: 9309923
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
27
02
2020
revised:
24
03
2020
accepted:
25
03
2020
pubmed:
2
4
2020
medline:
30
3
2021
entrez:
2
4
2020
Statut:
ppublish
Résumé
Chronic kidney disease stage 5 (CKD5) dialysis patients who stay long term in uremic environment often exhibit several, poorly defined, immune impairments. In this study, we assessed peripheral virus-specific effector/memory cells and subpopulations of T, B and DC cells using ELISPOT and FACS methods in 74 low-risk kidney transplant candidates without anti-HLA antibodies, prior to transplantation in pre-emptive (never experienced dialysis) and dialysis cohorts. There was difference in circulating marginal zone B cells (MZB) (IgD
Identifiants
pubmed: 32229239
pii: S0966-3274(20)30035-6
doi: 10.1016/j.trim.2020.101289
pii:
doi:
Substances chimiques
Tumor Necrosis Factor Receptor Superfamily, Member 7
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
101289Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors have no conflicts of interest to declare.